Essity B stock steadies as Brazil deal adds scale
Published on 08/22/2026 at 14:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Essity AB (publ) stock (SE0009922164) held near 270 SEK on August 21, 2026, after a 3,600-share chairman purchase at 272.40 SEK and a $284 million Brazil deal. The latest market snapshot showed 269.60 SEK, while the stock was up 1.49 percent year to date and down 2.30 percent over five trading days.
Brazil deal changes the mix
Essity agreed to buy Kenvue's feminine-care business in Brazil for $284 million, and the acquired portfolio generated 800 million BRL in net sales in the 12 months ended June 30, 2026. That revenue base is close to 1.4 billion SEK, which puts the acquisition at roughly 1.9 times trailing sales on the figures disclosed in the deal summary.
The package includes sanitary pads, liners, tampons and related production equipment in Brazil. It also gives Essity a larger position in feminine care in a market where brand loyalty and local distribution matter.
Chairman buys into weakness
Jan Gurander, Essity's chairman, bought 3,600 class B shares at 272.40 SEK each on August 21, 2026, for a reported total of 980,600 SEK. That purchase price sat just above the 269.60 SEK market indication and only slightly below the 272.30 SEK domestic quote shown in the same day's market data.
The comparison is useful for investors: the chairman bought at a level that matched the narrow recent trading band rather than chasing a sharp move. With the stock still up 1.49 percent year to date, the latest trade reads as a confidence signal more than a price breakout.
Latest interim backdrop
The latest reported quarter ended June 30, 2026, which keeps Essity's Q2 2026 numbers inside the current reporting window. That matters because the Brazil acquisition now lands against a fresh interim backdrop rather than an old fiscal-year comparison.
The combination of a June 30, 2026 reporting period, an August 21, 2026 insider purchase and a newly announced $284 million transaction gives the stock three dated reference points in one line of sight. For market readers, that is enough to anchor both the corporate story and the current trading range.
Feminine-care portfolio
Carefree, Sempre Livre and o.b. are the core brands Essity is adding in Brazil. Together they cover pads, liners and tampons, giving the company a broader consumer platform in a category that already fits its hygiene and health portfolio.
The business generated 800 million BRL in the 12 months ended June 30, 2026, which gives a concrete scale marker for the asset Essity is buying. That number, alongside the 2.7 billion SEK purchase price cited in the deal summary, is the key valuation anchor for the acquisition.
Price and market view
As of August 21, 2026, Essity B was quoted at 269.60 SEK in late CBOE trading, with the same market snapshot showing a 5-day move of minus 2.30 percent and a year-to-date gain of 1.49 percent. The stock's recent band around 270 SEK leaves the Brazil transaction and insider activity as the clearest fresh drivers for now.
The share price and acquisition math together show a company still trading in a tight range while adding a business with 800 million BRL in trailing sales. That combination keeps Essity B anchored to current market data and a specific corporate action rather than a broad market theme.
More on Essity B stock
Essity's investor story now centers on how quickly the Brazil feminine-care assets can be integrated and whether the new revenue stream can lift group growth in the quarters ahead.
Fact box
Company: Essity AB (publ)
ISIN: SE0009922164
Ticker: ESSITY B
Exchange: Nasdaq Stockholm
Price (as of August 21, 2026, 5:25 p.m. ET): SEK 269.60
Sector / Industry: Hygiene and health products
